Chemicals · Founded 1988 · www.igpetro.com · BSE 500199 · NSE I.G.PETRO · ISIN INE204A01010
No Notes Added Yet
Business
IG Petrochemicals Ltd. (IGPL) is a leading Indian manufacturer of Phthalic Anhydride (PA). The company's core business involves the large-scale production of PA, a key intermediate chemical. PA is derived primarily from Orthoxylene (OX) feedstock and is crucial for various industries, including plasticizers (for PVC), unsaturated polyester resins (UPR), alkyd resins (paints, coatings), dyes, and pharmaceuticals. IGPL's business model focuses on efficient manufacturing and distribution of this chemical intermediate. It generates revenue from the sale of PA, with profitability largely dependent on the spread between raw material costs (Orthoxylene) and the selling price of PA, along with conversion efficiencies.
Revenue Mix
IGPL's primary business segment and overwhelming contributor to its revenue is the manufacturing and sale of Phthalic Anhydride (PA). While it may produce some related by-products, PA constitutes the vast majority of its product portfolio and revenue stream.
Industry
IGPL operates within the Indian chemicals sector, specifically the petrochemicals industry, which is capital-intensive and subject to global commodity cycles. The market for Phthalic Anhydride in India is relatively consolidated. IGPL holds a dominant position as one of the largest, if not the largest, domestic producer of PA. This positioning provides it with significant market share, access to a wide customer base across diverse industries, and potential cost advantages over smaller domestic players and import competition due to its scale of operations.
MOAT
Economies of Scale: As a leading manufacturer of PA in India, IGPL benefits from large-scale production, which helps in achieving cost efficiencies in manufacturing and procurement of key raw materials like Orthoxylene.
Market Leadership: Its significant market share in India provides strong brand recognition within its niche, established customer relationships, and a competitive edge against new entrants.
High Entry Barriers: The manufacturing of chemicals like PA is capital-intensive, requires specialized technology, and complex environmental clearances, acting as a deterrent for new players.
Operational Efficiencies: Long-standing experience and continuous investment in process improvements contribute to optimizing production costs.
Growth Drivers
Growing Domestic Demand: Phthalic Anhydride demand is closely tied to the growth of India's end-user industries such as construction (PVC, paints, coatings), automotive, packaging, and infrastructure development.
Capacity Expansion: IGPL has a history of undertaking capacity expansions. Future expansions, driven by robust demand, will directly contribute to revenue and volume growth.
Import Substitution: Government initiatives like 'Make in India' and potential trade policies favoring domestic manufacturing could reduce reliance on imports and boost demand for local producers.
Product Diversification (Potential): While currently focused on PA, future growth could come from strategic diversification into related downstream products or higher-value derivatives, though PA remains core.
Risks
Raw Material Price Volatility: The primary raw material, Orthoxylene (OX), is a crude oil derivative. Fluctuations in crude oil prices and global OX supply-demand dynamics directly impact IGPL's cost of production and profitability.
Product Price Volatility: PA prices are cyclical and subject to global demand-supply imbalances, international competition, and broader economic conditions, leading to potential margin pressures.
Import Competition: Cheaper imports, especially from regions with overcapacity or lower production costs, can exert downward pressure on domestic PA prices.
Environmental & Regulatory Risks: Strict environmental norms and compliance costs, along with changing regulations in the chemical sector, can impact operations and capital expenditure.
Economic Slowdown: A significant slowdown in the Indian economy or global recession could reduce demand from key end-user industries, affecting sales volumes and prices.
Forex Fluctuations: Dependence on imported raw materials exposes the company to foreign exchange rate volatility.
Management & Ownership
IG Petrochemicals Ltd. is a promoter-led company, part of the IG Group. The promoter group, known to be the Gupta family, holds a significant stake in the company, indicating aligned long-term interests with shareholders. The management team is generally perceived to have deep experience and expertise in the chemical manufacturing sector, particularly in Phthalic Anhydride production and market dynamics.
Outlook
IGPL's outlook is influenced by its dominant position in the Indian Phthalic Anhydride market and the growth prospects of its end-user industries. The company stands to benefit from India's economic growth and associated demand for construction materials, plastics, and industrial coatings. Successful execution of capacity expansion plans and maintaining cost efficiencies could further strengthen its market leadership and profitability. However, the cyclical nature of petrochemicals, marked by volatility in raw material (Orthoxylene) and finished product (PA) prices, remains a key challenge. Intense competition from imports and potential shifts in global trade dynamics or regulatory landscape also pose risks. The company's ability to navigate these external factors while leveraging its scale and operational expertise will be crucial for its sustained performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 554 | 585 | 583 | 558 | 480 | 470 | 465 | 465 | 524 | 618 |
| Other Income | 9 | 9 | 4 | 8 | 5 | 10 | 6 | 5 | 5 | 7 |
| Total Income | 563 | 594 | 587 | 566 | 485 | 480 | 471 | 471 | 529 | 624 |
| Total Expenditure | 528 | 523 | 520 | 511 | 433 | 471 | 445 | 457 | 458 | 506 |
| Operating Profit | 35 | 71 | 67 | 55 | 52 | 9 | 26 | 14 | 72 | 119 |
| Interest | 9 | 9 | 16 | 3 | 11 | 9 | 11 | 10 | 11 | 11 |
| Depreciation | 15 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 20 | 18 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 45 | 34 | 36 | 25 | -16 | -1 | -13 | 40 | 90 |
| Provision for Tax | 2 | 10 | 8 | 8 | 6 | -3 | 1 | -2 | 12 | 24 |
| Profit After Tax | 9 | 35 | 26 | 29 | 19 | -13 | -2 | -11 | 28 | 66 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 9 | 35 | 26 | 29 | 19 | -13 | -2 | -11 | 28 | 66 |
| Adjusted Earnings Per Share | 2.9 | 11.4 | 8.5 | 9.3 | 6.2 | -4.2 | -0.7 | -3.5 | 9.1 | 21.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 953 | 1037 | 1144 | 1304 | 1059 | 1124 | 1883 | 2352 | 2099 | 2206 | 1925 | 2072 |
| Other Income | 4 | 8 | 4 | 11 | 6 | 6 | 11 | 22 | 31 | 26 | 26 | 23 |
| Total Income | 956 | 1046 | 1148 | 1315 | 1065 | 1129 | 1894 | 2374 | 2130 | 2232 | 1951 | 2095 |
| Total Expenditure | 840 | 874 | 877 | 1081 | 987 | 827 | 1480 | 2035 | 1994 | 1987 | 1830 | 1866 |
| Operating Profit | 117 | 171 | 271 | 234 | 78 | 302 | 414 | 340 | 136 | 245 | 120 | 231 |
| Interest | 23 | 18 | 15 | 12 | 16 | 15 | 13 | 24 | 30 | 39 | 41 | 43 |
| Depreciation | 18 | 21 | 26 | 26 | 30 | 34 | 44 | 47 | 52 | 65 | 69 | 70 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -8 | -0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 77 | 132 | 230 | 187 | 32 | 253 | 356 | 268 | 53 | 141 | 10 | 116 |
| Provision for Tax | 16 | 30 | 84 | 70 | 11 | 65 | 92 | 68 | 14 | 32 | 8 | 35 |
| Profit After Tax | 60 | 102 | 146 | 117 | 21 | 188 | 265 | 200 | 40 | 109 | 2 | 81 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 60 | 102 | 146 | 117 | 21 | 188 | 265 | 200 | 40 | 109 | 2 | 81 |
| Adjusted Earnings Per Share | 19.5 | 33 | 47.4 | 37.9 | 6.8 | 61.1 | 85.9 | 65 | 12.8 | 35.3 | 0.7 | 26.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -13% | -6% | 11% | 7% |
| Operating Profit CAGR | -51% | -29% | -17% | 0% |
| PAT CAGR | -98% | -78% | -60% | -29% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 34% | 5% | -7% | 9% |
| ROE Average | 0% | 4% | 11% | 17% |
| ROCE Average | 3% | 7% | 15% | 22% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 292 | 392 | 528 | 629 | 633 | 822 | 1062 | 1235 | 1247 | 1339 | 1333 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 92 | 60 | 29 | 101 | 147 | 90 | 114 | 169 | 226 | 162 | 147 |
| Other Non-Current Liabilities | 2 | 4 | 77 | 82 | 87 | 83 | 82 | 94 | 103 | 110 | 173 |
| Total Current Liabilities | 193 | 203 | 225 | 334 | 294 | 329 | 392 | 494 | 559 | 601 | 647 |
| Total Liabilities | 578 | 658 | 860 | 1146 | 1161 | 1324 | 1651 | 1992 | 2135 | 2211 | 2300 |
| Fixed Assets | 322 | 324 | 403 | 389 | 471 | 701 | 736 | 717 | 1030 | 1016 | 958 |
| Other Non-Current Assets | 26 | 44 | 142 | 312 | 364 | 181 | 204 | 464 | 261 | 320 | 453 |
| Total Current Assets | 230 | 290 | 315 | 445 | 326 | 442 | 712 | 811 | 844 | 875 | 889 |
| Total Assets | 578 | 658 | 860 | 1146 | 1161 | 1324 | 1651 | 1992 | 2135 | 2211 | 2300 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 18 | 1 | 3 | 5 | -14 | 1 | 32 | 16 | 14 | -15 | 16 |
| Cash Flow from Operating Activities | 69 | 94 | 201 | 139 | 84 | 183 | 109 | 233 | 37 | 261 | 102 |
| Cash Flow from Investing Activities | -6 | -42 | -164 | -216 | -104 | -72 | -106 | -255 | -115 | -92 | -89 |
| Cash Flow from Financing Activities | -64 | -50 | -35 | 58 | 35 | -80 | -19 | 21 | 48 | -138 | -53 |
| Net Cash Inflow / Outflow | -1 | 2 | 2 | -19 | 15 | 30 | -15 | -2 | -29 | 31 | -39 |
| Closing Cash & Cash Equivalent | 17 | 3 | 5 | -14 | 1 | 32 | 16 | 14 | -15 | 16 | -24 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 19.54 | 32.98 | 47.42 | 37.94 | 6.78 | 61.08 | 85.89 | 64.95 | 12.83 | 35.3 | 0.72 |
| CEPS(Rs) | 25.24 | 39.84 | 55.76 | 46.54 | 16.49 | 72.16 | 100.29 | 80.35 | 29.75 | 56.49 | 23.15 |
| DPS(Rs) | 2 | 3 | 4 | 4 | 2 | 7.5 | 10 | 10 | 7.5 | 10 | 5 |
| Book NAV/Share(Rs) | 94.69 | 127.15 | 171.38 | 204.28 | 205.46 | 266.93 | 344.9 | 401.01 | 404.91 | 434.75 | 432.83 |
| Core EBITDA Margin(%) | 10.91 | 14.36 | 22.83 | 17.05 | 6.77 | 26.38 | 21.37 | 13.51 | 5.02 | 9.93 | 4.92 |
| EBIT Margin(%) | 9.57 | 13.22 | 20.95 | 15.25 | 4.52 | 23.78 | 19.61 | 12.42 | 3.99 | 8.13 | 2.67 |
| Pre Tax Margin(%) | 7.38 | 11.61 | 19.67 | 14.32 | 3.01 | 22.49 | 18.92 | 11.41 | 2.54 | 6.37 | 0.54 |
| PAT Margin (%) | 5.8 | 8.94 | 12.47 | 8.96 | 1.97 | 16.74 | 14.05 | 8.5 | 1.88 | 4.93 | 0.12 |
| Cash Profit Margin (%) | 7.5 | 10.8 | 14.67 | 10.99 | 4.8 | 19.78 | 16.4 | 10.52 | 4.37 | 7.88 | 3.7 |
| ROA(%) | 10.4 | 16.43 | 19.24 | 11.65 | 1.81 | 15.14 | 17.78 | 10.98 | 1.91 | 5 | 0.1 |
| ROE(%) | 20.64 | 29.73 | 31.77 | 20.2 | 3.31 | 25.86 | 28.08 | 17.42 | 3.18 | 8.41 | 0.17 |
| ROCE(%) | 24.34 | 34.07 | 45.07 | 27.67 | 5.68 | 28.91 | 33.25 | 21.5 | 5.42 | 11.15 | 3.12 |
| Receivable days | 38.3 | 41.55 | 44.97 | 45.02 | 56.23 | 55.56 | 52.88 | 52.08 | 57.49 | 51.45 | 60.26 |
| Inventory Days | 31.52 | 29.92 | 29.77 | 31.33 | 38.71 | 38.81 | 28.69 | 24.6 | 31.7 | 40.82 | 47.47 |
| Payable days | 76.69 | 78.95 | 80.42 | 75.94 | 95.94 | 117.81 | 75.95 | 68.2 | 78.74 | 89.77 | 102.02 |
| PER(x) | 5.27 | 11.38 | 13.53 | 7.87 | 13.66 | 6.78 | 8.16 | 6.33 | 33.52 | 12.03 | 463.99 |
| Price/Book(x) | 1.09 | 2.95 | 3.74 | 1.46 | 0.45 | 1.55 | 2.03 | 1.03 | 1.06 | 0.98 | 0.77 |
| Dividend Yield(%) | 1.94 | 0.8 | 0.62 | 1.34 | 2.16 | 1.81 | 1.43 | 2.43 | 1.74 | 2.36 | 1.5 |
| EV/Net Sales(x) | 0.44 | 1.16 | 1.78 | 0.83 | 0.44 | 1.22 | 1.17 | 0.56 | 0.72 | 0.63 | 0.62 |
| EV/Core EBITDA(x) | 3.57 | 7.05 | 7.53 | 4.61 | 5.97 | 4.52 | 5.33 | 3.9 | 11.08 | 5.69 | 9.95 |
| Net Sales Growth(%) | 0 | 8.88 | 10.28 | 13.94 | -18.8 | 6.14 | 67.56 | 24.94 | -10.77 | 5.11 | -12.75 |
| EBIT Growth(%) | 0 | 51.33 | 63.36 | -18.94 | -75.92 | 458.07 | 38.17 | -20.85 | -71.32 | 113.99 | -71.32 |
| PAT Growth(%) | 0 | 68.75 | 43.78 | -19.98 | -82.13 | 800.99 | 40.61 | -24.38 | -80.25 | 175.09 | -97.96 |
| EPS Growth(%) | 0 | 68.75 | 43.78 | -19.98 | -82.13 | 800.99 | 40.61 | -24.38 | -80.25 | 175.09 | -97.96 |
| Debt/Equity(x) | 0.4 | 0.21 | 0.16 | 0.31 | 0.36 | 0.2 | 0.16 | 0.2 | 0.29 | 0.2 | 0.27 |
| Current Ratio(x) | 1.19 | 1.43 | 1.4 | 1.33 | 1.11 | 1.34 | 1.81 | 1.64 | 1.51 | 1.46 | 1.37 |
| Quick Ratio(x) | 0.73 | 0.95 | 1.02 | 0.96 | 0.78 | 0.91 | 1.43 | 1.31 | 1.15 | 0.97 | 1.05 |
| Interest Cover(x) | 4.38 | 8.23 | 16.42 | 16.37 | 3 | 18.36 | 28.66 | 12.22 | 2.76 | 4.62 | 1.25 |
| Total Debt/Mcap(x) | 0.37 | 0.07 | 0.04 | 0.21 | 0.81 | 0.13 | 0.08 | 0.2 | 0.28 | 0.2 | 0.35 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 |
| FII | 3.01 | 2.5 | 2.73 | 2.79 | 3.1 | 3.11 | 2.96 | 2.88 | 2.92 | 2.67 |
| DII | 1.79 | 2.15 | 2.7 | 2.64 | 1.44 | 0.96 | 0.96 | 1.21 | 1.46 | 1.61 |
| Public | 26.47 | 26.61 | 25.84 | 25.83 | 26.73 | 27.19 | 27.35 | 27.18 | 26.88 | 26.98 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 |
| FII | 0.09 | 0.08 | 0.08 | 0.09 | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | 0.08 |
| DII | 0.06 | 0.07 | 0.08 | 0.08 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 |
| Public | 0.82 | 0.82 | 0.8 | 0.8 | 0.82 | 0.84 | 0.84 | 0.84 | 0.83 | 0.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -13% | -6% | +11% | +7% |
| Operating Profit CAGR | -51% | -29% | -17% | 0% |
| PAT CAGR | -98% | -78% | -60% | -29% |
| Share Price CAGR | +34% | +5% | -7% | +9% |
| ROE Average | 0% | +4% | +11% | +17% |
| ROCE Average | +3% | +7% | +15% | +22% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 | 68.74 |
| FII | 3.01 | 2.5 | 2.73 | 2.79 | 3.1 | 3.11 | 2.96 | 2.88 | 2.92 | 2.67 |
| DII | 1.79 | 2.15 | 2.7 | 2.64 | 1.44 | 0.96 | 0.96 | 1.21 | 1.46 | 1.61 |
| Public | 26.47 | 26.61 | 25.84 | 25.83 | 26.73 | 27.19 | 27.35 | 27.18 | 26.88 | 26.98 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 |
| FII | 0.09 | 0.08 | 0.08 | 0.09 | 0.1 | 0.1 | 0.09 | 0.09 | 0.09 | 0.08 |
| DII | 0.06 | 0.07 | 0.08 | 0.08 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 |
| Public | 0.82 | 0.82 | 0.8 | 0.8 | 0.82 | 0.84 | 0.84 | 0.84 | 0.83 | 0.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.